LONDON, March 13, 2014 /PRNewswire/ --

The trading session on Wednesday, March 12, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,340.08, down 0.07% and the NASDAQ Composite closed at 4,323.33, up 0.37%. The S&P 500 finished the session 0.03% higher at 1,868.20. The gains were narrow based as four of ten sectors ended the session in positive. The session saw a positive impact from Utilities, Information Technology and Consumer Staple sectors, while the day's drag came in from Industrials, Telecommunication Services and Financial sectors. Investor-Edge.com looks at some of the equities which were most active during the session. These include Geron Corp. (NASDAQ:GERN), Herbalife Ltd (NYSE:HLF), Nu Skin Enterprises Inc. (NYSE:NUS), and Chimera Investment Corp. (NYSE:CIM). Free research on these four companies can be accessed at:

http://investor-edge.com/register

On Wednesday, shares in Geron Corp. recorded heavy trading as a total of 46.47 million shares changed hands, against a three-month average volume of 4.71 million shares. The stock finished the day at $1.69, down 61.59% and at an intraday range of $1.39 and $1.82. Geron Corp.'s shares have fallen by 62.69% in the past three trading sessions, 66.86% in the last one month, and 64.35% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 3.36% in the last one month, while the NASDAQ Composite Index went up by 2.90% during the same period. The stock is trading below its 50-day and 200-day moving averages of $4.85 and $3.30, respectively. The company's shares are trading at an RSI of 39.20. Sign up and read the free notes on GERN at:

http://www.Investor-Edge.com/03132014/GERN/report.pdf

Herbalife Ltd's stock saw heavy trading as a total of 15.98 million shares changed hands on Wednesday, as compared with the three-month average volume of 3.52 million shares. The stock closed the day at $60.57, down 7.37% and at an intraday range of $54.59 and $69.41. Shares of the company traded at a PE ratio of 11.28. Herbalife Ltd's shares have lost 6.44% in the past three trading sessions, 7.65% in the last one month, and 23.04% on YTD basis. The S&P 500 Consumer Staples Sector Index mapped a gain of 2.94% in the last one month, while the S&P 500 gained 2.69% during the same period. The stock is trading below its 50-day and 200-day moving averages of $70.04 and $64.04, respectively. The company's shares have an RSI of 44.52. The complimentary notes on HLF can be downloaded as in PDF format at:

http://www.Investor-Edge.com/03132014/HLF/report.pdf

Shares in Nu Skin Enterprises Inc. recorded heavy trading as a total of 12.44 million shares changed hands on Wednesday, as compared with the three-month average volume of 2.52 million shares. The stock ended the day at $77.89, up 6.53% and at an intraday trading range of $68.02 and $81.85. The stock traded at a PE ratio of 13.11. Nu Skin Enterprises Inc.'s shares have advanced 2.08% in the past three trading sessions, and 3.83% in the last one month, while falling by 43.65% on YTD basis. The S&P 500 Consumer Staples Sector Index mapped a gain of 0.77% in the last three months, while the S&P 500 was up by 5.22% during the same period. The stock is trading below its 50-day and 200-day moving averages of $93.55 and $93.63, respectively. The stock is trading at an RSI of 35.99. Register for free on Investor-Edge and access the latest research on NUS at:

http://www.Investor-Edge.com/03132014/NUS/report.pdf

Chimera Investment Corp.'s shares saw heavy trading as a total of 12.11 million shares were exchanged, against a three-month average volume of 6.91 million shares. On Wednesday, the stock ended the day at $3.15, up 1.61% and with an intraday fluctuation between $3.08 and $3.15. Shares of the company traded at a PE ratio of 8.75. Chimera Investment Corp.'s shares have gained 0.64% in the past three trading sessions, 0.96% in the last one month, and 8.53% on YTD basis. The S&P 500 Financials Sector Index mapped a gain of 3.02% in the last one month, while the S&P 500 was up by 2.69% during the same period. The stock is trading above its 50-day and 200-day moving averages of $3.08 and $2.88, respectively. The company's shares have an RSI of 46.33. The complete research on CIM is available for free at:

http://www.Investor-Edge.com/03132014/CIM/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

============= 


        
        - This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        - Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        - This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        - If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at pubco [at] Investor-edge.com.
        - For any urgent concerns or inquiries, please contact us at compliance [at]
          Investor-edge.com.
        - Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research [at] Investor-edge.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge